Evidence map›Paper›PMID 26455503›Full record

ReviewImmunology2016

Programmed DNA breaks in lymphoid cells: repair mechanisms and consequences in human disease.

Jana Prochazkova, Joanna I Loizou

Open access · hybridAbstract readReview
In one paragraph

Review in Immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Immune Aging in Rheumatoid Arthritis.Arthritis & rheumatology (Hoboken, N.J.) · 2025
    Review
  3. Review
  4. Methylomic Investigation of Problematic Adolescent Cannabis Use and Its Negative Mental Health Consequences.Journal of the American Academy of Child and Adolescent Psychiatry · 2021
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Consider the workhorse: Nonhomologous end-joining in budding yeast.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2016
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jana ProchazkovaCeMM Research Centre for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Joanna I LoizouCeMM Research Centre for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Austrian Academy of Sciences · AT

Funding

Austrian Science Fund FWF P 24766
6 · The paper itself

Abstract

In recent years, several novel congenital human disorders have been described with defects in lymphoid B-cell and T-cell functions that arise due to mutations in known and/or novel components of DNA repair and damage response pathways. Examples include impaired DNA double-strand break repair, as well as compromised DNA damage-induced signal transduction, including phosphorylation and ubiquitination. These disorders reinforce the importance of genome stability pathways in the development of lymphoid cells in humans. Furthermore, these conditions inform our knowledge of the biology of the mechanisms of genome stability and in some cases may provide potential routes to help exploit these pathways therapeutically. Here we review the mechanisms that repair programmed DNA lesions that occur during B-cell and T-cell development, as well as human diseases that arise through defects in these pathways.

Indexed as

AnimalsB-LymphocytesCell Transformation, NeoplasticDNA DamageDNA RepairDNA Repair-Deficiency DisordersGenetic Predisposition to DiseaseHumansMutationNeoplasmsPhenotypeRecombination, GeneticT-Lymphocytescancerclass switch recombinationDNA repairimmunodeficiencynon-homologous end-joiningV(D)J recombination

Identifiers

PMID26455503
PMCPMC4988471
OpenAlexW1921480600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.